Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA5 | P31644 | 1/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3999942 | 0.88 | GABRA5 (0.51) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| SCHEMBL2789164 | 0.88 | GABRA5 (0.51) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| Hydrochloric Acid SCHEMBL8913011 | 0.87 | GABRA5 (0.50) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| SCHEMBL8896803 | 0.82 | NPC1 (0.47) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| SCHEMBL8896790 | 0.82 | NPC1 (0.47) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| SCHEMBL10404051 | 0.81 | HSD17B10 (0.33) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| SCHEMBL8723035 | 0.78 | MAPT (0.44) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| SCHEMBL9089346 | 0.78 | MAPT (0.44) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| SCHEMBL8768619 | 0.78 | GABRA5 (0.38) | GABRA5GABRB2HSD17B10MAPTRAB9A | |
| SCHEMBL8135644 | 0.75 | GABRA5 (0.43) | GABRA5GABRB2HSD17B10MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7335767-B2 | Method for preparation of ceftiofur and salts thereof | LUPIN LIMITED (IN) | 2008-02-26 | — | — | US | disclosed |
| US-20040132996-A1 | Method for preparation of ceftiofur and salts thereof | LUPIN LIMITED | 2004-07-08 | — | — | US | disclosed |
| US-5656623-A | BACTERICIDES; ANTIBIOTICS | THE PROCTER & GAMBLE COMPANY (US) | 1997-08-12 | — | — | US | disclosed |
| EP-0366189-A2 | Novel antimicrobial lactam-quinolones | Norwich Eaton Pharmaceuticals, Inc. (US) | 1990-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132996-A1 | Method for preparation of ceftiofur and salts thereof | MRPL21, ME1, CA6 | GABRA5 2704/4885GABRB2 2405/4885HSD17B10 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.